Increased levels of soluble tumour necrosis factor receptor-I (P55) and decreased IgG1 reactivities in HIV-1 patients with cytomegalovims disease

Scandinavian Journal of Immunology

Volumn 47, Issue 6, 1998, Pages 591-595

  Jakobsen, P H ^a   Dodt, K K ^b   Meyer, C N ^a   Katzenstein, T ^a   Gerstoft, J ^a   Skinhoj P ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; INFECTION SENSITIVITY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, VIRAL; ANTIGENS, CD; ANTIGENS, VIRAL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HIV-1; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, VIRAL; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 0031747849     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00338.x     Document Type: Article

References (18)

1. Hansen KK, Richsten A, Hofmann B, Norrild B, Olofsson S, Mathiesen L. Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. J Infect Dis 1994;170:1271-4.
2. Poli G, Kinter A, Justement JS et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 1990; 87:782-5.
3. Stein J, Volk H-D, Liebenthal C, Kruger DH, Prosch S. Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promotor in immature monocytic cells. J Gen Virol 1993;74:2333-8.
4. Docke WD, Prosch S, Fietze E. et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994;343:268-9.
5. Dembic Z, Loetscher H, Gubler U. et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990;2:231-7.
6. Loetscher H, Pan YCE, Lahm HW. et al. Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 1990;61:351-9.
7. Dodt KK, Jakobsen PH, Hofmann B. et al. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS 1997;11:F21-8.
8. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation with viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73.
9. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodefiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989;86:5974-8.
10. Kalinkovich A, Engelmann H, Harpaz N. et al. Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol 1992;89:351-5.
11. Godfried MH, van der Poll T, Jansen J et al. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 1993;7:33-6.
12. Kruppa G, Thooma B, Machleidt T, Wiegmann K, Kronke M. Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockage of the human 55-kDa TNF receptor. J Immunol 1992;148:3152-7.
13. Zack Howard OM, Clouse KA, Smith C, Goodwin RG, Farrar WL. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation. Proc Natl Acad Sci USA 1993;90:2335-9.
14. Blick M, Sherwin SA, Rosenblum M, Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987;47:2986-9.
15. Ferrante A, Beard LJ, Robertson DM. IgG subclass deficiency. Pediatr Allergy Immunol 1991;2:49-62.
16. Linde GA, Hammerstrom L, Persson MAA, Smith CIE, Sundqvist V-A, Wahren B. Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infec Immun 1983;42:237-44.
17. Kanoh Y, Yunoki M, Taniguchi T et al. Development of human monoclonal antibodies against human cytomegalovirus. Hybridoma 1992;11:569-79.
18. Boppana SB, Polis MA, Kramer AA, Britt WJ, Koenig S. Virus-specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected persons with HCMV retinitis. J Infect Dis 1995;171:182-5.